Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

EtCO2 for Monitoring and Predicting Severity of DKA in Pediatric Emergency, Doha, Qatar.

NCT04121572 is registered in ClinicalTrials.gov with Hamad Medical Corporation as lead sponsor.

NCT NCT04121572
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04121572 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
EtCO2 for Monitoring and Predicting Severity of DKA in Pediatric Emergency, Doha, Qatar.
Lead sponsor
Hamad Medical Corporation
Phase
Observational
Overall status
Unknown status
Start date
October 10, 2019
Completion date
December 31, 2024
Enrollment
150 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

diabetes mellitus